Molecular Partners AG announced to-day its results for the financial-year 2014. 2014 was a transformational year for Molecular Partners, marked by several developments that allowed the company to leverage the strengths of its novel DARPin technology platform, of its strategic partnerships as well as of its proprietary pipeline.
Monthly Archives: March 2015
Molecular Partners AG is pleased to announce the appointment of Dr. Andreas Harstrick as Chief Medical Officer (CMO) and new member of the Executive Management Team.
Molecular Partners AG [SIX:MOLN] today announced that its CFO, Andreas Emmenegger, will present at the Cowen and Company 35th Annual Healthcare Conference on Tuesday 03 March 2015 at 8:00 AM Eastern Time (2:00 PM CET).